3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
5
Tumor-Agnostic
2
Gastrointestinal
2
Conditions
Neoplasms
1
Neoplasm, Residual
1
Interventions
pembrolizumab
26
Specimen Handling
22
Biopsy
22
Magnetic Resonance Spectroscopy
20
Paclitaxel
12
Carboplatin
10
Blood Specimen Collection
10
Bevacizumab
10
atezolizumab
9
Standard of Care
9
Nivolumab
9
Cisplatin
8
Radiosurgery
7
Pemetrexed
7
Gemcitabine
6
Cyclophosphamide
6
Capecitabine
6
trastuzumab deruxtecan
5
durvalumab
5
X-Rays
5
Taxes
5
Surveys and Questionnaires
5
Irinotecan
5
Fluorouracil
5
olaparib
4
niraparib
4
cabozantinib
4
Radiotherapy
4
Oxaliplatin
4
Leucovorin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hematologic Tests
×
Tumor-Agnostic
×
90 days
×
Clear all
NCT07514715
2026-04-13
RT4
The Lymphoma Academic Research Organisation
Not yet recruiting
129 enrolled
NCT06999785
2026-04-06
OXYBAR
University Hospital, Angers
Phase NA
Recruiting
60 enrolled